EyePoint Pharmaceuticals's total assets for Q1 2025 were $362.56M, a decrease of -13.36% from the previous quarter. EYPT total liabilities were $64.17M for the fiscal quarter, a -21.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.